Product Information

RISEDRONATE SODIUM 150 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $12.8176 per EA under NDC 65862087003. Its NADAC has been published 498 times since Feb 8, 2017.

FDA first approved this application on Oct 21, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RISEDRONATE SODIUM 150 MG TAB

Risedronate Sodium
$12.8176per EA

Strength

150 mg/1

NDC

65862087003

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

RISEDRONATE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA206768

FDA Approved

10/21/2016

TE Code

AB

On Market Since

10/21/2016

Pharmacological Classes

Bisphosphonate
Diphosphonates

Price Statistics

The NADAC for RISEDRONATE SODIUM 150 MG TAB has been published 498 times since Feb 8, 2017, and over the history we have for it it has declined 86.0%. The table below summarizes its recorded NADAC range and movement.

Current price$12.8176 per EA
All-time high$91.4002 (Feb 15, 2017)
All-time low$9.8142 (May 22, 2024)
52-week high$17.6823
52-week low$12.8176
Median price$30.9967
Average price$30.6716
Largest weekly change+58.0% (Aug 21, 2024)
Weeks tracked498
Tracking sinceFeb 8, 2017

Price History

1W

-6.7%

1M

-6.7%

3M

-20.1%

6M

-24.6%

1Y

-27.5%

3Y

-1.8%

5Y

-58.2%

All

-86.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RISEDRONATE SODIUM 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 150 MG TAB, manufactured by Aurobindo Pharma Limited, is $12.8176 per EA (NDC 65862087003), effective Aug 19, 2026.

How has the price of RISEDRONATE SODIUM 150 MG TAB changed over time?

Over the history we have for it, the NADAC for RISEDRONATE SODIUM 150 MG TAB has declined 86.0%. It has been tracked across 498 weekly CMS publications since Feb 8, 2017.

What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 150 MG TAB?

Since Feb 8, 2017, the NADAC for RISEDRONATE SODIUM 150 MG TAB has ranged from a low of $9.8142 (May 22, 2024) to a high of $91.4002 (Feb 15, 2017), with a median of $30.9967 per EA.

Are there cheaper alternatives to RISEDRONATE SODIUM 150 MG TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RISEDRONATE SODIUM 150 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures RISEDRONATE SODIUM 150 MG TAB?

RISEDRONATE SODIUM 150 MG TAB (NDC 65862087003) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.